Bio-Rad Laboratories (BIO) stock news · P/E 43, rev $2.58B
Bio-Rad Laboratories (BIO) common stock.
This BIO news page leads with what Bio-Rad Laboratories filed — not a scraped headline mill.
No cached 8-K sentence for BIO yet. We will not pad this page with generic market recap.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. BIO currently screens at trailing P/E 43.1.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BIO stock page; for the tape open the quote page.
BIO stock news FAQ
What are BIO's latest revenue and net income?
Latest cached Bio-Rad Laboratories (BIO) revenue for Dec 31, 2025 was $2.58B. Net income was $759.9M. Statements: https://lician.com/financials/bio
What is BIO's P/E ratio?
Bio-Rad Laboratories (BIO) trailing P/E is 43.1 on the latest cached fundamentals snapshot.
Where is BIO stock news listed?
Cached stock news for Bio-Rad Laboratories (BIO) is listed at https://lician.com/news/bio. Filings: https://lician.com/sec/bio
Not investment advice.